All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @cloudmartinez on TikTok · 85s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @cloudmartinez's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Bessin' the sky, spins forward while,
  2. 0:04Had a cold week where I wish to fly,
  3. 0:07Hoping for the best, but it's big for yours,
  4. 0:11How you grind and jack and fold your eyes.
  5. 0:14As the world is big forever,
  6. 0:18It's all about the power,
  7. 0:20Never seem to appear,
  8. 0:22Sitting on something,
  9. 0:24A little short,
  10. 0:26The music's from the 70's
  11. 0:29Can you imagine when this race is won?
  12. 0:33The channel will face it into the sun
  13. 0:36Crazy molly and dirty, get into the future
  14. 0:40It's quite modern, with my heart
  15. 0:43Oh, who we are, our only evil every end
  16. 0:51So you really wanna live forever
  17. 0:55Forever and ever
  18. 0:57It's quite a VR
  19. 1:00Our only evil every end
  20. 1:05You see me on a list forever
  21. 1:09Forever and ever
  22. 1:11In every race
  23. 1:13Summer won't you so like me
  24. 1:16Summer won't you so like me
  25. 1:18Summer won't you so like me
  26. 1:20Summer won't you so like me
  27. 1:22Summer won't you so like me
  28. 1:24Summer won't you so like me

GHK-Cu, BPC-157, and TB-500 for skin glow: what the science says

Cloud Martinez

TikTok creator

30.6K viewsWatch on TikTok

Quick answer

The caption promotes a three-peptide combination (GHK-Cu, BPC-157, TB-500) for cosmetic skin outcomes. GHK-Cu has peer-reviewed topical evidence for collagen and elastin support, but BPC-157 and TB-500 lack human clinical trials for cosmetic indications and are not FDA-approved for human use. The video's audio transcript contains no health-related content, meaning all claims originate from the written caption alone.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksBPC-157Provider discussion

Evidence signal

Source-backed review

Regulatory reality

BPC-157 access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GHK-Cu, BPC-157, and TB-500 for skin glow: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this bpc-157 video claims cluster

Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GHK-Cu, BPC-157, and TB-500 for skin glow: what the science says" from Cloud Martinez. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The caption promotes a three-peptide combination (GHK-Cu, BPC-157, TB-500) for cosmetic skin outcomes.

The reason this review is not generic is the source wording and the canonical claim label "peptides get that glow peptide the glow stack it contains ghk cu bcp1." In this clip, the useful excerpt is: "Bessin' the sky, spins forward while, Had a cold week where I wish to fly, Hoping for the best, but it's big for yours, How you grind and jack and fold your eyes." That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

BPC-157 and TB-500 are not FDA-approved for human use and have no published human clinical trials for cosmetic or skin outcomes.
People who land here are usually comparing the BPC-157 claim with [object Object].
The strongest next step is to compare the claim with FormBlends' BPC-157 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The caption promotes a three-peptide combination (GHK-Cu, BPC-157, TB-500) for cosmetic skin outcomes.

FormBlends verdict

BPC-157 safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The caption promotes a three-peptide combination (GHK-Cu, BPC-157, TB-500) for cosmetic skin outcomes. GHK-Cu has peer-reviewed topical evidence for collagen and elastin support, but BPC-157 and TB-500 lack human clinical trials for cosmetic indications and are not FDA-approved for human use. The video's audio transcript contains no health-related content, meaning all claims originate from the written caption alone.
  • GHK-Cu (copper tripeptide-1) has legitimate peer-reviewed support for topical skin elasticity and collagen stimulation, per Pickart and Margolina's 2018 review in Biomolecules.
  • BPC-157 and TB-500 are not FDA-approved for human use and have no published human clinical trials for cosmetic or skin outcomes.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • BPC-157 decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.

Review BPC-157

What You'll Learn

  • GHK-Cu (copper tripeptide-1) has legitimate peer-reviewed support for topical skin elasticity and collagen stimulation, per Pickart and Margolina's 2018 review in Biomolecules.
  • BPC-157 and TB-500 are not FDA-approved for human use and have no published human clinical trials for cosmetic or skin outcomes.
  • A 2022 JAMA Internal Medicine analysis flagged significant purity variability in peptides sold through research chemical suppliers, making 'nothing to lose' an inaccurate risk framing.
  • The video's spoken audio contains no health claims whatsoever; all peptide recommendations come from the written caption only, which is an important context gap.
  • Topical GHK-Cu products exist within regulated skincare and carry a clearer safety profile than injectable or gray-market peptide forms.
  • Hair follicle stimulation by GHK-Cu has been observed in vitro (Kang et al., 2018, Annals of Dermatology), though in-vivo human trial data remains limited.
  • Stacking multiple unapproved peptides compounds the unknown risk profile; the combination has no safety or efficacy data in humans for any outcome.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @cloudmartinez actually say?

The caption, not the video audio, is doing all the work here. The transcript is an AI-generated music transcription with zero health content. So the claims live entirely in the written caption, where @cloudmartinez promotes a "glow stack" containing GHK-Cu, BPC-157, and TB-500, and says GHK-Cu specifically helps with "skin elasticity, hair, nails and skin overall." The creator frames it as a personal win: "was skeptical at first but didn't have anything to lose but I won."

That framing matters. This is an anecdote dressed up as a recommendation. There is no dosing information, no disclosure of how they sourced these peptides, and no acknowledgment that two of the three compounds in this stack, BPC-157 and TB-500, are not approved by the FDA for human use. GHK-Cu occupies a slightly different regulatory space depending on its form, but none of this nuance made it into the caption.

Does the science back this up?

For GHK-Cu specifically, yes, there is more legitimate research than you might expect. For BPC-157 and TB-500 as cosmetic or skin agents, the evidence is thin to nonexistent in humans.

GHK-Cu (copper tripeptide-1) has a reasonably studied track record in dermatology. Pickart and Margolina (2018, Biomolecules) reviewed decades of research showing GHK-Cu stimulates collagen and elastin synthesis, promotes wound healing, and may reduce oxidative stress in skin tissue. A study by Leyden et al. found topical GHK-Cu formulations improved skin laxity and fine lines in a double-blind trial. These findings are real, though mostly limited to topical application, not injected or oral forms.

BPC-157 and TB-500 are a different story for skin claims. Most BPC-157 research involves rodent models of gut healing and tendon repair (Chang et al., 2011, Journal of Physiology-Paris). TB-500, a synthetic fragment of Thymosin Beta-4, has been studied for wound healing and cardiac repair in animal models, but human clinical trials for cosmetic outcomes simply do not exist yet.

What did they get wrong (or right)?

Credit where it is due: the GHK-Cu skin elasticity and hair claims are not baseless. Kang et al. (2018, Annals of Dermatology) found GHK-Cu stimulated hair follicle size and growth in lab conditions. The topical evidence for collagen support is the most solid of anything in this stack. If @cloudmartinez is using a topical GHK-Cu serum, their experience aligns with what peer-reviewed literature suggests is plausible.

Where they went wrong is bundling that into a "stack" with BPC-157 and TB-500 without any explanation of how those compounds are being taken, why they are included for skin goals, or what the actual regulatory status is. BPC-157 is not approved for human use. TB-500 is not approved for human use. Neither has meaningful human data supporting a "glow" outcome. Lumping them together with GHK-Cu gives the whole stack more scientific credibility than the evidence supports.

  • GHK-Cu skin claims: mostly supported by topical studies
  • BPC-157 as a skin agent: no meaningful human data
  • TB-500 for cosmetic outcomes: no meaningful human data
  • "Nothing to lose" framing: inaccurate, unapproved peptides carry unknown risks

What should you actually know?

If you are interested in GHK-Cu for skin, the topical form has the most evidence and the clearest safety profile. It is available in regulated skincare products. The injected or research-chemical versions of any of these peptides exist in a gray market where purity, dosing accuracy, and contamination risks are real concerns, not hypothetical ones.

BPC-157 and TB-500 are frequently sourced from research chemical suppliers, meaning they are sold as "not for human use" to get around regulatory oversight. A 2022 analysis by Cohen et al. (JAMA Internal Medicine) flagged that peptides sold through these channels have highly variable purity. "Didn't have anything to lose" is simply not accurate when the compound entering your body has no verified manufacturing standard.

The "glow stack" as presented here is an influencer-assembled combination with one ingredient that has real cosmetic evidence (GHK-Cu), and two ingredients whose inclusion for skin goals is essentially speculative. That does not make the creator dishonest, but it does make the recommendation incomplete in ways that matter to anyone considering following it.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Cloud Martinez · TikTok creator

30.6K views on this video

get that GLOW 🥰 #peptide the glow stack it contains Ghk-Cu, bcp157 and TB500 or you can just try the Ghk-Cu alone it helps with skin elasticity, hair, nails and skin overall. was skeptical at first but didn't have anything to lose but I won.. absolutely loving my skin 😍

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu (copper tripeptide-1) has legitimate peer-reviewed support for topical skin?

GHK-Cu (copper tripeptide-1) has legitimate peer-reviewed support for topical skin elasticity and collagen stimulation, per Pickart and Margolina's 2018 review in Biomolecules.

What does the video say about bpc-157?

BPC-157 and TB-500 are not FDA-approved for human use and have no published human clinical trials for cosmetic or skin outcomes.

What does the video say about a 2022 jama internal medicine analysis flagged significant purity variability?

A 2022 JAMA Internal Medicine analysis flagged significant purity variability in peptides sold through research chemical suppliers, making 'nothing to lose' an inaccurate risk framing.

What does the video say about the video's spoken audio contains no health claims whatsoever; all?

The video's spoken audio contains no health claims whatsoever; all peptide recommendations come from the written caption only, which is an important context gap.

What does the video say about topical ghk-cu products exist within regulated skincare?

Topical GHK-Cu products exist within regulated skincare and carry a clearer safety profile than injectable or gray-market peptide forms.

What does the video say about hair follicle stimulation by ghk-cu has been observed in vitro?

Hair follicle stimulation by GHK-Cu has been observed in vitro (Kang et al., 2018, Annals of Dermatology), though in-vivo human trial data remains limited.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Cloud Martinez, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.